Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) dropped 3.2% during trading on Friday after an insider sold shares in the company. Arcutis Biotherapeutics Stock PerformanceThe firm has a 50 day simple moving average of $16.44 and a 200-day simple moving average of $15.07. Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. Arcutis Biotherapeutics Company Profile(Get Free Report)Arcutis Biotherapeutics, Inc, a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Recommended StoriesReceive News & Ratings for Arcutis Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcutis Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.